Share
Market Research Report

GLOBAL SOLIRIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By IndicationParoxysmal Nocturnal Hemoglobinuria (PNH) · Atypical Hemolytic Uremic Syndrome (aHUS) · Generalized Myasthenia Gravis (gMG) · and Neuromyelitis Optica Spectrum Disorder (NMOSD)
  • By Age GroupPediatric · Adult · and Geriatric
  • By End UserHospitals · Specialty Clinics · Infusion Centers · and Others (Academic & Research Institutions, etc.)
  • Published In11 Mar 2026
  • Report CodeCMI8143
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  •  Indication Insights (Revenue, USD Mn, 2021 - 2033)

    • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • Atypical Hemolytic Uremic Syndrome (aHUS)
    • Generalized Myasthenia Gravis (gMG)
    • Neuromyelitis Optica Spectrum Disorder (NMOSD)
  •  Age Group Insights (Revenue, USD Mn, 2021 - 2033)

    • Pediatric
    • Adult
    • Geriatric
  •  End User Insights (Revenue, USD Mn, 2021 - 2033)

    • Hospitals
    • Specialty Clinics
    • Infusion Centers
    • Others (Academic & Research Institutions,etc.)
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa